7 drug makers fined for illicit rebates

Published: 2009-01-20 07:00:00

Updated: 2009-01-20 07:00:00

The country’s corporate watchdog said on January 15 that it has imposed a combined 20.4 billion won in fines on seven pharmaceutical companies for unfair trading practices, including the provision of illegal rebates to hospitals and wholesalers.

The Fair Trade Commission (FTC) said GlaxoSmithK...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK